Bausch Health Companies Inc. Q3 FY2021 Earnings Call

Bausch Health Companies Inc. (BHC)

Earnings Call FY2021 Q3 Call date: 2021-11-02 Concluded

Quarter scorecard

Revenue

$2.11B

-1.3% YoY

Diluted EPS

$0.52

+160% YoY

Net income

$188.00M

+164.8% YoY

Pharmaceutical Products $941.00M

-3.6%

Device Products $469.00M

+8.6%

Over the Counter Products $409.00M

+9.4%

Branded and Other Generic Products $269.00M

-18.2%

Product And Service Other $23.00M

-14.8%